Print
Presentation Center
Contents Search
A list of resources from presentations given by AVAC:
-
Finding Your Way: A guide to understanding ethical issues related to preventive HIV vaccine clinical trial participation
*
Jul 1, 2005 - AVAC
Developed by AVAC in partnership with the International Council of AIDS Service Organizations (ICASO), this guide provides an introduction to the ethical principles raised in preventive HIV vaccine research and development, and examples of some of the actions taken to honor those principles.
-
Vertical Transmission Funding
- AVAC
-
Vertical Transmission Prevention Funding
- AVAC
In 2009
-
Total Investment in HIV Prevention as Percentage of GDP
- AVAC
In Vaccines, Microbicides and Other HIV Prevention Options as a Percentage of Country Gross Domestic Product
-
HIV Therapeutic Vaccine Investment
- AVAC
In 2009
-
Pre-Exposure Prophylaxis Funding
- AVAC
2002-2009 (US$ Millions)
-
Philanthropic Investment toward HIV Vaccine R&D
- AVAC
By Foundations and Companies in 2009
-
Microbicide Funding
- AVAC
2000-2009 (US$ Millions); By Sector (Commercial, Philanthropic, and Public)
-
Expenditure Distribution for Public and Philanthropic Funding for Microbicide R&D
- AVAC
2006-2009 (US$ Millions)
-
Male Circumcision Funding
- AVAC
2001-2009 (US$ Millions)
-
Annual Investment in Male Circumcision
- AVAC
2005-2009 (US$ Millions)
-
HIV Vaccine Funding
- AVAC
2000-2009 (US$ Millions); By Sector (Commercial, Philanthropic, and Public)
-
HIV Vaccine Expenditures
- AVAC
2001-2009
-
HIV Trial Participants
- AVAC
By Country 2009
-
Annual Investment in Vaccine R&D
- AVAC
2005-2009 (US$ Millions)
-
Annual Investment in Microbicide R&D
- AVAC
2005-2009 (US$ Millions)